Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Outcome of 127 Cases of Splanchnic Venous Thrombosis: Benefit of Anticoagulant Therapy

Lucia Canafoglia, MD, Serena Rupoli, MD, Gianluca Svegliati Baroni, MD, Michele Gironella, MD, Giorgia Micucci, MD, Irene Federici, BSc, Massimo Offidani, Alessandro Fiorentini, MD, Alessandra Riva, MD, Lidia Da Lio, MD, Anna Rita Scortechini, MD, Elisa Honorati, MD, Pietro Leoni, Prof

Blood (2016) 128 (22): 2610.

https://doi.org/10.1182/blood.V128.22.2610.2610

Published: 2016

Journal Articles

Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splanchnic or Cerebral Venous Thrombosis

Serena Rupoli, MD, Lucia Canafoglia, MD, Gianluca Svegliati Baroni, MD, Michele Gironella, MD, Giorgia Micucci, MD, Irene Federici, BSc, Massimo Offidani, Gaia Goteri, MD, Alessandro Fiorentini, MD, Alessandra Riva, MD, Lidia Da Lio, MD, Leandro Provinciali, MD, Anna Rita Scortechini, MD, Elisa Honorati, MD, Pietro Leoni, Prof

Blood (2016) 128 (22): 4257.

https://doi.org/10.1182/blood.V128.22.4257.4257

Published: 2016

Journal Articles

Risk of Thromboembolic Events in ET and Early/Prefibrotic PMF: The Relevance of an Accurate Histological Diagnosis

Serena Rupoli, MD, Gaia Goteri, MD, Picardi Picardi, MD, Lucia Canafoglia, MD, Giorgia Micucci, MD, Anna Rita Scortechini, MD, Irene Federici, Federica Giantomassi, Lidia Da Lio, MD, Antonio Zizzi, Pietro Leoni, MD

Blood (2012) 120 (21): 1735.

https://doi.org/10.1182/blood.V120.21.1735.1735

Published: 2012

Journal Articles

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

Serena Rupoli, MD, Nicola Pimpinelli, MD, Gaia Goteri, MD, Lucia Canafoglia, MD, Paola Picardi, Giuliano Brandozzi, MD, Stefano Pulini, Irene Federici, PhD, Anna Rita Scortechini, md, Simona Tomassetti, MD, Lisa Albani, MD, Lidia Da Lio, MD, Mirella Giangiacomi, Pietro Leoni, MD

Blood (2010) 116 (21): 3953.

https://doi.org/10.1182/blood.V116.21.3953.3953

Published: 2010

Journal Articles

Impact of Jak2V617F Mutational Status on Essential Thrombocythemia: An Assessment of Thrombotic Risk Factors on 218 Patients

Anna Rita Scortechini, MD, Serena Rupoli, MD, Lisa Albani, MD, Simonetta Mulattieri, Paola Picardi, Lidia Da Lio, MD, Berardinelli Eleonora, Simona Tomassetti, MD, Lucia Canafoglia, MD, Pietro Leoni, MD

Blood (2010) 116 (21): 3072.

https://doi.org/10.1182/blood.V116.21.3072.3072

Published: 2010

NARROW

Clinical Outcome of 127 Cases of Splanchnic Venous Thrombosis: Benefit of Anticoagulant Therapy

Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splanchnic or Cerebral Venous Thrombosis

Risk of Thromboembolic Events in ET and Early/Prefibrotic PMF: The Relevance of an Accurate Histological Diagnosis

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

Impact of Jak2V617F Mutational Status on Essential Thrombocythemia: An Assessment of Thrombotic Risk Factors on 218 Patients

Email alerts

ASH Publications

American Society of Hematology

Clinical Outcome of 127 Cases of Splanchnic Venous Thrombosis: Benefit of Anticoagulant Therapy

Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splanchnic or Cerebral Venous Thrombosis

Risk of Thromboembolic Events in ET and Early/Prefibrotic PMF: The Relevance of an Accurate Histological Diagnosis

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

Impact of Jak2V617F Mutational Status on Essential Thrombocythemia: An Assessment of Thrombotic Risk Factors on 218 Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only